SG
CVS icon

StoneX Group’s CVS Health CVS Stock Holding History

StoneX Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.83M Sell
25,437
-5,754
-18% -$443K 0.1% 169
2025
Q4 		$2.48M Buy
31,191
+19
+0.1% +$1.5K 0.11% 153
2025
Q3 		$2.35M Sell
31,172
-1,093
-3% -$74.9K 0.1% 172
2025
Q2 		$2.23M Buy
32,265
+1,176
+4% +$77.1K 0.11% 168
2025
Q1 		$2.11M Buy
31,089
+2,483
+9% +$149K 0.12% 159
2024
Q4 		$1.28M Buy
+28,606
New +$1.6M 0.07% 239
2022
Q2 		– Sell
-11,602
Closed -$1.17M – 571
2022
Q1 		$1.17M Sell
11,602
-1,499
-11% -$157K 0.11% 160
2021
Q4 		$1.35M Buy
13,101
+1,755
+15% +$162K 0.16% 136
2021
Q3 		$963K Sell
11,346
-1,080
-9% -$90.5K 0.14% 158
2021
Q2 		$1.04M Buy
12,426
+665
+6% +$54.5K 0.15% 145
2021
Q1 		$885K Buy
11,761
+1,099
+10% +$80.1K 0.16% 134
2020
Q4 		$728K Buy
10,662
+2,023
+23% +$132K 0.16% 135
2020
Q3 		$505K Buy
8,639
+264
+3% +$16.4K 0.16% 148
2020
Q2 		$544K Buy
8,375
+1,272
+18% +$80.1K 0.21% 127
2020
Q1 		$421K Sell
7,103
-2,065
-23% -$138K 0.22% 131
2019
Q4 		$681K Buy
9,168
+1,243
+16% +$87.3K 0.28% 107
2019
Q3 		$500K Buy
7,925
+1,135
+17% +$67.3K 0.31% 113
2019
Q2 		$370K Buy
+6,790
New +$366K 0.24% 132
2017
Q3 		– Sell
-40,559
Closed -$3.26M – 213
2017
Q2 		$3.26M Buy
40,559
+29,968
+283% +$2.37M 1.02% 7
2017
Q1 		$836K Sell
10,591
-79
-0.7% -$6.31K 1.87% 18
2016
Q4 		$842K Buy
+10,670
New +$863K 1.47% 22

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

StoneX Group's CVS Position: Q1 2026 in Review

StoneX Group reduced its CVS Health (CVS) stake by 18% in Q1 2026, selling an estimated $443K and leaving 25,437 shares worth $1.83M. The position accounts for 0.1% of the portfolio, ranked #169.

StoneX Group first reported a position in CVS in Q4 2016 and has held it in 21 quarters since. The position peaked at $3.26M in Q2 2017. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • StoneX Group held 25,437 shares of CVS Health worth $1.83M as of Q1 2026.
  • StoneX Group sold 5,754 CVS Health shares in Q1 2026, an estimated $443K.
  • CVS Health made up 0.1% of StoneX Group's portfolio in Q1 2026, its #169 holding.
  • StoneX Group first reported a position in CVS Health in Q4 2016 and has held it in 21 quarters since.
  • StoneX Group's CVS Health position peaked at $3.26M in Q2 2017.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.